A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST scoreJan-Alexis Tremblay, Laurence Quéméneur, Christophe Védrine et al.|Annals of Intensive Care|2022Cited by 37
REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageStephan A. Mayer, Manfred Westphal, Nicolas Bruder et al.|Journal of neurosurgery|2024Cited by 31
Integrated clustering of multiple immune marker trajectories reveals different immunotypes in severely injured patientsMaxime Bodinier, Marie Matray, Estelle Peronnet et al.|Critical Care|2024Cited by 16
Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) StudyEstelle Peronnet, Sophie Blein, Fabienne Venet et al.|Critical Care Medicine|2023Cited by 12